Evidence map›Paper›PMID 35884505›Full record

ArticleCancers2022

Colorectal Cancer Stem Cells Fuse with Monocytes to Form Tumour Hybrid Cells with the Ability to Migrate and Evade the Immune System.

Karla Montalbán-Hernández, Ramón Cantero-Cid, José Carlos Casalvilla-Dueñas, José Avendaño-Ortiz, Elvira Marín, Roberto Lozano-Rodríguez, Verónica Terrón-Arcos, Marina Vicario-Bravo, Cristóbal Marcano, Jorge Saavedra-Ambrosy and 8 more

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.9field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Implications of Heterotypic Cell Fusion in Cancer.Advances in experimental medicine and biology · 2026
    Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Advancements in 3D In Vitro Models for Colorectal Cancer.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Review
  11. Review
  12. Cell Fusion and Syncytia Formation in Cancer.Results and problems in cell differentiation · 2024
    Review
  13. Article
  14. Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 2 institutions in 1 country.

Karla Montalbán-HernándezThe Innate Immune Response Group, IdiPAZ, La Paz University Hospital, 28046 Madrid, Spain.ORCID 0000-0002-1612-103X
Ramón Cantero-CidThe Innate Immune Response Group, IdiPAZ, La Paz University Hospital, 28046 Madrid, Spain.
José Carlos Casalvilla-DueñasThe Innate Immune Response Group, IdiPAZ, La Paz University Hospital, 28046 Madrid, Spain.
José Avendaño-OrtizThe Innate Immune Response Group, IdiPAZ, La Paz University Hospital, 28046 Madrid, Spain.ORCID 0000-0003-2774-1821
Elvira MarínThe Innate Immune Response Group, IdiPAZ, La Paz University Hospital, 28046 Madrid, Spain.ORCID 0000-0003-2206-2328
Roberto Lozano-RodríguezThe Innate Immune Response Group, IdiPAZ, La Paz University Hospital, 28046 Madrid, Spain.ORCID 0000-0003-0093-9707
Verónica Terrón-ArcosThe Innate Immune Response Group, IdiPAZ, La Paz University Hospital, 28046 Madrid, Spain.
Marina Vicario-BravoDigestive Surgery Service, La Paz Univeristy Hospital, 28046 Madrid, Spain.
Cristóbal MarcanoDigestive Surgery Service, La Paz Univeristy Hospital, 28046 Madrid, Spain.
Jorge Saavedra-AmbrosyDigestive Surgery Service, La Paz Univeristy Hospital, 28046 Madrid, Spain.
Julia Prado-MonteroThe Innate Immune Response Group, IdiPAZ, La Paz University Hospital, 28046 Madrid, Spain.
Jaime ValentínThe Innate Immune Response Group, IdiPAZ, La Paz University Hospital, 28046 Madrid, Spain.
Rebeca Pérez de DiegoThe Innate Immune Response Group, IdiPAZ, La Paz University Hospital, 28046 Madrid, Spain.
Laura CórdobaThe Innate Immune Response Group, IdiPAZ, La Paz University Hospital, 28046 Madrid, Spain.
Elisa PulidoThe Innate Immune Response Group, IdiPAZ, La Paz University Hospital, 28046 Madrid, Spain.
Carlos Del FresnoThe Innate Immune Response Group, IdiPAZ, La Paz University Hospital, 28046 Madrid, Spain.ORCID 0000-0003-1771-7254
Marta DueñasMolecular Oncology Unit, Biomedical Innovation Department, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), 28040 Madrid, Spain.ORCID 0000-0003-0857-9726
Eduardo López-CollazoThe Innate Immune Response Group, IdiPAZ, La Paz University Hospital, 28046 Madrid, Spain.
Hospital Universitario La Paz · ESCentre for Biomedical Network Research on Rare Diseases · ES

Funding

Fundación Familia Alonso ELCFundación para la Investigación Biomédica La Paz, (FIBHULP) ELCLa Caixa 713673
6 · The paper itself

Abstract

backgroundThe cancer cell fusion theory could be one of the best explanations for the metastasis from primary tumours.

methodsHerein, we co-cultured colorectal cancer (CRC) stem cells with human monocytes and analysed the properties of the generated tumour hybrid cells (THCs). The presence of THCs in the bloodstream together with samples from primary and metastatic lesions and their clinical correlations were evaluated in CRC patients and were detected by both FACS and immunofluorescence methods. Additionally, the role of SIGLEC5 as an immune evasion molecule in colorectal cancer was evaluated.

resultsOur data demonstrated the generation of THCs after the in vitro co-culture of CRC stem cells and monocytes. These cells, defined as CD45

conclusionsOur results indicate the generation of a hybrid entity after the in vitro co-culture between CRC stem cells and human monocytes. Moreover, THC numbers present in patients are related to both prognosis and the later spread of metastases in CRC patients.

Indexed as

colorectal cancerfusionmetastasismonocytesSIGLEC5tumour hybrid cell

Identifiers

PMID35884505
PMCPMC9324286
OpenAlexW4285733687

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.